Jupiter Asset Management Ltd. Reduces Position in Corteva, Inc. $CTVA

Jupiter Asset Management Ltd. cut its position in shares of Corteva, Inc. (NYSE:CTVA) by 57.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 415,289 shares of the company’s stock after selling 561,157 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in Corteva were worth $27,837,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Activest Wealth Management boosted its stake in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC purchased a new position in shares of Corteva during the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva during the 3rd quarter worth about $29,000. Jackson Grant Investment Advisers Inc. boosted its stake in shares of Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the period. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in shares of Corteva during the 3rd quarter worth about $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Down 2.7%

Shares of Corteva stock opened at $78.41 on Friday. The firm’s 50 day moving average price is $81.33 and its 200-day moving average price is $74.53. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The company has a market cap of $52.44 billion, a P/E ratio of 46.12, a PEG ratio of 2.47 and a beta of 0.59.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter in the previous year, the firm earned $1.13 EPS. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CTVA shares. Citigroup lifted their price target on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Wells Fargo & Company lifted their price objective on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. Argus lifted their price objective on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Royal Bank Of Canada lifted their price objective on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, UBS Group lifted their price objective on shares of Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.